HYPOTHALAMOPITUITARY FUNCTION AND DOPAMINE DEPENDENCE IN UNTREATED PARKINSONIAN-PATIENTS

被引:15
作者
CUSIMANO, G [1 ]
CAPRIANI, C [1 ]
BONIFATI, V [1 ]
MECO, G [1 ]
机构
[1] UNIV ROME LA SAPIENZA,DEPT NEUROL SCI,I-00185 ROME,ITALY
来源
ACTA NEUROLOGICA SCANDINAVICA | 1991年 / 83卷 / 03期
关键词
PARKINSONS DISEASE; THYROTROPIN RELEASING HORMONE; PROLACTIN; THYROTROPIN; SOMATOTROPIN; BROMOCRIPTINE;
D O I
10.1111/j.1600-0404.1991.tb04666.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Altered prolactin and thyrotropin responses to the TRH test in parkinsonian patients are held to indicate an impairment of the tubero-infundibular dopaminergic axis (TIDA). We correlated the plasmatic prolactin (PRL), thyrotropin (TSH) and somatotropin (GH) responses to TRH and bromocriptine + TRH of 12 parkinsonian patients, who had never received anti-parkinsonian drugs, with the severity, the duration, the age of onset and the dopamine-dependence of the motor symptomatology as indicated by the therapeutic response to a six-month oral treatment with bromocriptine. Patients with basal motor impairment over 9 on the Webster Rating Scale (WRS), those with duration of the disease over 24 months and those with onset earlier than 55 years of age showed lower PRL responses than the respectively matched subgroups. Patients showing a therapeutic motor improvement over 50% on the WRS (dopamine-dependent or "responder") showed lower PRL and TSH and higher GH responses than the non-responders. These findings suggest that the TIDA impairment described in Parkinson's disease develops along with the progressive course of the extrapyramidal involvement and is strictly correlated with the dopamine-dependence of the motor impairment.
引用
收藏
页码:145 / 150
页数:6
相关论文
共 28 条
[1]  
Barbeau A., 1986, HDB CLIN NEUROLOGY, P87
[2]   ENDOCRINE FUNCTION AND GLUCOSE METABOLISM IN PATIENTS WITH PARKINSONS DISEASE AND THEIR ALTERATION BY L-DOPA [J].
BOYD, AE ;
LEBOVITZ, HE ;
FELDMAN, JM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1971, 33 (05) :829-+
[3]   EVIDENCE OF DOPAMINE-RECEPTORS IN HUMAN GROWTH-HORMONE (GH)-SECRETING ADENOMAS WITH CONCOMITANT STUDY OF DOPAMINE-INHIBITION OF GH SECRETION IN A PERIFUSION SYSTEM [J].
BRESSION, D ;
BRANDI, AM ;
NOUSBAUM, A ;
LEDAFNIET, M ;
RACADOT, J ;
PEILLON, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (03) :589-593
[4]   CHANGES IN PLASMA GROWTH-HORMONE LEVELS IN NORMAL AND ACROMEGALIC SUBJECTS FOLLOWING ADMINISTRATION OF 2-BROMO-ALPHA-ERGOCRYPTINE [J].
CAMANNI, F ;
MASSARA, F ;
BELFORTE, L ;
MOLINATTI, GM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1975, 40 (03) :363-366
[5]   EFFECT OF L-DOPA ADMINISTRATION ON GROWTH-HORMONE SECRETION IN NORMAL SUBJECTS AND PARKINSONIAN PATIENTS [J].
CAVAGNINI, F ;
BANA, R ;
SCOTTI, G ;
RAGGI, U ;
PONTIROLI, AE ;
PERACCHI, M .
JOURNAL OF ENDOCRINOLOGY, 1972, 54 (03) :425-+
[6]  
Debono A G, 1975, Lancet, V2, P987
[7]  
DIROSA AE, 1981, 8 ATT RIUN LEG IT CO, P266
[8]  
EISLER T, 1981, NEUROLOGY, V31, P1356, DOI 10.1212/WNL.31.10.1356
[9]   TUBEROINFUNDIBULAR DOPAMINERGIC FUNCTION IN PARKINSONS-DISEASE [J].
FRANCESCHI, M ;
CAMERLINGO, M ;
PEREGO, L ;
BOTTACCHI, E ;
TRUCI, G ;
MAMOLI, A .
EUROPEAN NEUROLOGY, 1988, 28 (03) :117-119
[10]   PLASMA DOPA LEVELS AND GROWTH-HORMONE RESPONSE TO LEVODOPA IN PARKINSONISM [J].
GALEADEBONO, A ;
JENNER, P ;
MARSDEN, CD ;
PARKES, JD ;
TARSY, D ;
WALTERS, J .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1977, 40 (02) :162-167